Statistics

Total Visits

Views
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo459

Total Visits Per Month

November 2025December 2025January 2026February 2026March 2026April 2026May 2026
The FDA‐Approved Antiviral Raltegravir Inhibits Fascin1‐Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo0291724132618

File Visits

Views
2021 RAL cancers.pdf164

Top country views

Views
United States126
Germany100
Ireland73
Singapore36
Hong Kong24
Brazil22
United Kingdom18
South Korea10
Spain7
Japan6

Top cities views

Views
Frankfurt am Main92
Dublin73
Ashburn34
Hong Kong20
London14
San Jose12
Singapore12
Social Circle10
Seoul9
Council Bluffs6